JPS5841894A - サンゲノン化合物 - Google Patents
サンゲノン化合物Info
- Publication number
- JPS5841894A JPS5841894A JP56141310A JP14131081A JPS5841894A JP S5841894 A JPS5841894 A JP S5841894A JP 56141310 A JP56141310 A JP 56141310A JP 14131081 A JP14131081 A JP 14131081A JP S5841894 A JPS5841894 A JP S5841894A
- Authority
- JP
- Japan
- Prior art keywords
- sangenone
- soluble
- extract
- methanol
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 23
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims abstract description 8
- 230000002378 acidificating effect Effects 0.000 claims abstract description 5
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims abstract description 4
- 238000003795 desorption Methods 0.000 claims abstract description 4
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims abstract description 4
- 230000008018 melting Effects 0.000 claims abstract description 4
- 238000002844 melting Methods 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 238000000862 absorption spectrum Methods 0.000 claims description 7
- 238000000354 decomposition reaction Methods 0.000 claims description 3
- 238000001819 mass spectrum Methods 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 238000012746 preparative thin layer chromatography Methods 0.000 claims description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 3
- 239000012279 sodium borohydride Substances 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 claims 1
- 241000218213 Morus <angiosperm> Species 0.000 claims 1
- 239000002798 polar solvent Substances 0.000 claims 1
- 238000010898 silica gel chromatography Methods 0.000 claims 1
- 235000008708 Morus alba Nutrition 0.000 abstract description 6
- 240000000249 Morus alba Species 0.000 abstract description 6
- 239000000843 powder Substances 0.000 abstract description 4
- 238000004440 column chromatography Methods 0.000 abstract description 3
- 239000012535 impurity Substances 0.000 abstract description 3
- 239000003960 organic solvent Substances 0.000 abstract description 3
- FOGVNFMUZXDMTR-UHFFFAOYSA-N [Mg].Cl Chemical compound [Mg].Cl FOGVNFMUZXDMTR-UHFFFAOYSA-N 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000000706 filtrate Substances 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 230000004531 blood pressure lowering effect Effects 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- -1 8-substituted cyclohexenylflavone Chemical class 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 3
- 241000218231 Moraceae Species 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000001459 whitebark Nutrition 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical group COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- TXHIDIHEXDFONW-UHFFFAOYSA-N benzene;propan-2-one Chemical compound CC(C)=O.C1=CC=CC=C1 TXHIDIHEXDFONW-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Compounds Of Unknown Constitution (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56141310A JPS5841894A (ja) | 1981-09-08 | 1981-09-08 | サンゲノン化合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56141310A JPS5841894A (ja) | 1981-09-08 | 1981-09-08 | サンゲノン化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5841894A true JPS5841894A (ja) | 1983-03-11 |
| JPH0228597B2 JPH0228597B2 (enrdf_load_stackoverflow) | 1990-06-25 |
Family
ID=15288915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56141310A Granted JPS5841894A (ja) | 1981-09-08 | 1981-09-08 | サンゲノン化合物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5841894A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61291526A (ja) * | 1985-06-19 | 1986-12-22 | Osaka Chem Lab | 桑及び／又はこの近縁種を原料とする成人病予防食品 |
| JPS62163732A (ja) * | 1986-01-16 | 1987-07-20 | Mitsubishi Heavy Ind Ltd | 排ガス中の窒素酸化物と一酸化炭素の同時処理方法 |
-
1981
- 1981-09-08 JP JP56141310A patent/JPS5841894A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61291526A (ja) * | 1985-06-19 | 1986-12-22 | Osaka Chem Lab | 桑及び／又はこの近縁種を原料とする成人病予防食品 |
| JPS62163732A (ja) * | 1986-01-16 | 1987-07-20 | Mitsubishi Heavy Ind Ltd | 排ガス中の窒素酸化物と一酸化炭素の同時処理方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0228597B2 (enrdf_load_stackoverflow) | 1990-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhao et al. | Six new eremophilane derivatives from two Ligularia species | |
| DK164866B (da) | Fremgangsmaade til isolering af isosilybinfrit silibinin | |
| JP4309769B2 (ja) | 新規なグルコピラノサイド、その分離方法、それを含む薬物及びその使用方法 | |
| JP2005179339A (ja) | 新規化合物および医薬組成物 | |
| JPS5841894A (ja) | サンゲノン化合物 | |
| Mock et al. | Chemical studies of the Proteaceae. VI Two naphthoquinones from Stenocarpus salignus | |
| Nyandat et al. | The 7, 7 ″-β-diglucoside of (2S, 3R)-chamaejasmin from Ormocarpum kirkii | |
| JPS58150584A (ja) | クワノン化合物 | |
| JPS6011017B2 (ja) | ジテルペンアルコ−ルの製法 | |
| JPS58150538A (ja) | クワノン化合物 | |
| EP1732875B1 (en) | Process for isolation of hepatoprotective agent "oleanolic acid" from lantana camara | |
| JPH0260680B2 (enrdf_load_stackoverflow) | ||
| JPH0228596B2 (enrdf_load_stackoverflow) | ||
| JPS5843990A (ja) | クワノン化合物 | |
| US6884908B2 (en) | Process for isolation of hepatoprotective agent “oleanolic acid” from Lantana camera | |
| Rogachev et al. | Some prenylated phenols of Rhododendron adamsii: isolation, modification and pharmacological tests | |
| Kon et al. | 114. Sapogenins. Part VIII. The sapogenin of Fuller's herb | |
| JPH0114232B2 (enrdf_load_stackoverflow) | ||
| Patton et al. | Quinoxaline Studies. III. The Preparation and Physical Properties of Some 2, 3-Dialkoxyquinoxalines | |
| JPS5857383A (ja) | 新規フラボノイド | |
| JP2585661B2 (ja) | テルペン化合物及びその製造法 | |
| JPS6287591A (ja) | 新規クアシノイド化合物およびその製造法 | |
| JPS595176A (ja) | 抗腫瘍剤 | |
| JPS6172719A (ja) | 抗高脂血症剤 | |
| JPH01207298A (ja) | プロトスタ−１３（１７）エン−３，１６−ジオン化合物 |